Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Concord Biosciences

Concord Biosciences
1986 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
7 FINANCING ROUNDS
2 INVESTMENTS
Description

Provider of contract research and chemical development services. The company's services offers comprehensive capabilities and conducts studies with all species commonly used in nonclinical research providing study information with insightful analysis enabling its clients in the Agricultural Chemicals industry with a comprehensive, integrated suite of services to accelerate drug development through all phases of drug development.

Formerly Known As
Ricerca Biosciences
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Specialty Chemicals
Pharmaceuticals
Parent Company
Primary Office
  • 10845 Wellness Way
  • Concord, OH 44077
  • United States

+1 (440) 000-0000

Concord Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Concord Biosciences‘s full profile, request access.

Request full access to PitchBook

Concord Biosciences Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vimta Labs Corporation Hyderabad, India 0000
0000000 0000000000 Private Equity-Backed Billerica, MA 00000 00.000 000000000 00.000
0000 Corporation Dublin, Ireland 00000 00000 000000000 00000
000000 Formerly PE-Backed Princeton, NJ 000 00000 000000&0 00000
00000000 Formerly PE-Backed Évreux, France 0000 000000&0
To view this company’s complete list of competitors, request access »

Concord Biosciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Aug-2010 00000 00000 00 Drug Discovery
MDS (Discovery & Pre-clinical Operations) 08-Mar-2010 Buyout/LBO 000.00 Drug Delivery 000 000000
To view this company’s complete investment and acquisition history, request access »

Concord Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 01-Aug-2010 00000 00000 00 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Concord Biosciences Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Concord Biosciences‘s full profile, request access.

Request full access to PitchBook

Concord Biosciences Executive Team (11)

Name Title Board
Seat
Contact
Info
Clifford Croley Chief Executive Officer

10 Former Executives

You’re viewing 1 of 11 executives. Get the full list »